Fig. 3

PRMT6 Is Associated with YTHDF2 and Promotes Its Expression. A: Differential analysis based on PRMT6 mRNA expression levels in glioma samples from the CGGA database, categorized into “high PRMT6 expression” and “low PRMT6 expression” groups. B: Correlation analysis of PRMT6 and YTHDF2 using mRNA sequencing data from glioma in the CGGA database. C: Correlation analysis of PRMT6 and YTHDF2 in glioma using mRNA sequencing data from the TCGA database. D: Correlation analysis of PRMT6 and YTHDF2 in glioma using protein data from the CPTAC database. E-F: Examination of YTHDF2 protein and mRNA expression in LN229 and U251 cells with or without PRMT6 knockdown. G-H: Analysis of YTHDF2 protein and mRNA expression in U87 and U118 cells with or without PRMT6 overexpression. I-J: Evaluation of PRMT6 protein and mRNA expression in LN229 and U251 cells with or without YTHDF2 knockdown. K-L: Assessment of PRMT6 protein and mRNA expression in LN229 and U251 cells with or without YTHDF2 overexpression